Transcode Therapeutics | 8-K: Current report
Transcode Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Transcode Therapeutics | EFFECT: Others
Transcode Therapeutics | D: Filing D
Transcode Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Transcode Therapeutics | 8-K: Current report
Transcode Therapeutics | 8-K: Current report
Transcode Therapeutics | 8-K: Current report
Transcode Therapeutics | 10-Q: Q3 2024 Earnings Report
Transcode Therapeutics | DEFA14A: Others
Transcode Therapeutics | DEFA14A: Others
Transcode Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-3i, LP(0%),3i Management LLC(0%), etc.
Transcode Therapeutics | 8-K: Current report
Transcode Therapeutics | DEF 14A: Definitive information statements
Transcode Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Transcode Therapeutics | 8-K: Current report
Transcode Therapeutics | 8-K: Current report
Transcode Therapeutics | 8-K: Current report
Transcode Therapeutics | 10-Q: Q2 2024 Earnings Report
Transcode Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-3i, LP(9.9%),3i Management LLC(9.9%), etc.
Unlock the Full List